Since cancer stemness and drug resistance confer to survival of cancer patients, our results suggest that elevated PFKFB4 might modulate signaling pathway required for drug resistance and cancer stemness, which in turn to contribute worse survival of oral cancer patients. This evidence concerns the gene PFKFB4 and lip and oral cavity carcinoma.